SCHEMBL3412905

SCHEMBL3412905

CN1CCN(C2(Cc3ccccc3)CCC(CN)CC2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.46
RAD52 P43351 1/20 0.46
KMT2A Q03164 1/20 0.46
NCF1 P14598 1/20 0.41
MC4R P32245 1/20 0.40
PRMT3 O60678 1/20 0.38
CARM1 Q86X55 1/20 0.38
PRMT6 Q96LA8 1/20 0.38
PRMT1 Q99873 1/20 0.38
PRMT8 Q9NR22 1/20 0.38
SIGMAR1 Q99720 4/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
BCHE P06276 1/20 0.36
OPRM1 P35372 3/20 0.36
HTR6 P50406 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34
HCN1 O60741 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4118539 0.84 CARM1 (0.39) GAARAD52KMT2AMC4RCARM1
SCHEMBL4112299 0.84 TSHR (0.39) GAARAD52KMT2ANCF1PRMT3
SCHEMBL14279644 0.82 GAA (0.55) GAARAD52KMT2AMC4RSIGMAR1
SCHEMBL4124999 0.77 KMT2A (0.44) GAARAD52KMT2AMC4RSIGMAR1
SCHEMBL735929 0.76 KMT2A (0.43) GAARAD52KMT2AMC4RSIGMAR1
SCHEMBL734090 0.74 KMT2A (0.41) GAARAD52KMT2AMC4RSIGMAR1
SCHEMBL4130873 0.73 CYP2D6 (0.43) GAARAD52KMT2AMC4RSIGMAR1
SCHEMBL4124967 0.73 CXCR4 (0.39) CARM1PRMT6SIGMAR1CXCR4
SCHEMBL4130743 0.73 MAOA (0.41) SIGMAR1MAOAMAOBOPRM1OPRD1
SCHEMBL296400 0.72 MAOA (0.43) MAOAMAOBBCHEOPRM1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257527-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-12-08 EP disclosed
US-20090253669-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-08 US disclosed
WO-2009115257-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2009-09-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253669-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 GAA 621/4885RAD52 4626/4885KMT2A 1309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.